Company Description
XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally.
It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler’s spa services, including massage, nail, and skin care services, as well as spa and travel products.
The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC’s bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.
The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services.
The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs.
The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022.
XWELL, Inc. is based in New York, New York.
| Country | United States |
| Founded | 2006 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 337 |
| CEO | Ezra Ernst |
Contact Details
Address: 254 West 31st Street, 11th Floor New York, New York 10001 United States | |
| Phone | (212)-750-9595 |
| Website | xwell.com |
Stock Details
| Ticker Symbol | XWEL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001410428 |
| CUSIP Number | 98420U802 |
| ISIN Number | US98420U8027 |
| SIC Code | 7200 |
Key Executives
| Name | Position |
|---|---|
| Ezra T. Ernst | President and Chief Executive Officer |
| Suzanne Scrabis | Chief Financial Officer |
| Scott R. Milford | Consultant |
| Omar A. Haynes | Vice President of Treasury and Finance |
| Cara Soffer | Senior Vice President and General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Sep 23, 2024 | 8-K | Current Report |
| Sep 5, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Sep 5, 2024 | 8-K | Current Report |
| Aug 21, 2024 | DEF 14A | Other definitive proxy statements |
| Aug 16, 2024 | PRER14A | Filing |
| Aug 16, 2024 | 8-A12B | Registration of securities |
| Aug 16, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Aug 16, 2024 | 8-K | Current Report |